BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 15710567)

  • 1. Identification of growth factor conditions that reduce ex vivo cord blood progenitor expansion but do not alter human repopulating cell function in vivo.
    Levac K; Karanu F; Bhatia M
    Haematologica; 2005 Feb; 90(2):166-72. PubMed ID: 15710567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
    Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different growth factor requirements for the ex vivo amplification of transplantable human cord blood cells in a NOD/SCID mouse model.
    Bruno S; Gammaitoni L; Gunetti M; Sanavio F; Fagioli F; Aglietta M; Piacibello W
    J Biol Regul Homeost Agents; 2001; 15(1):38-48. PubMed ID: 11388743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells.
    Rossmanith T; Schröder B; Bug G; Müller P; Klenner T; Knaus R; Hoelzer D; Ottmann OG
    Stem Cells; 2001; 19(4):313-20. PubMed ID: 11463951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The plant mannose-binding lectin NTL preserves cord blood haematopoietic stem/progenitor cells in long-term culture and enhances their ex vivo expansion.
    Li K; Ooi VE; Chuen CK; Lam AC; Ooi LS; Zhang XB; Tsang KS; Chiu LC; Chan KY; Li CK; Fok TF; Yuen PM; Ng PC
    Br J Haematol; 2008 Jan; 140(1):90-8. PubMed ID: 17908183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice.
    Fei XM; Wu YJ; Chang Z; Miao KR; Tang YH; Zhou XY; Wang LX; Pan QQ; Wang CY
    Cytotherapy; 2007; 9(4):338-47. PubMed ID: 17573609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo megakaryocyte differentiation of fresh and ex-vivo expanded cord blood cells: rapid and transient megakaryocyte reconstitution.
    Bruno S; Gunetti M; Gammaitoni L; Danè A; Cavalloni G; Sanavio F; Fagioli F; Aglietta M; Piacibello W
    Haematologica; 2003 Apr; 88(4):379-87. PubMed ID: 12681964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor.
    Ueda T; Tsuji K; Yoshino H; Ebihara Y; Yagasaki H; Hisakawa H; Mitsui T; Manabe A; Tanaka R; Kobayashi K; Ito M; Yasukawa K; Nakahata T
    J Clin Invest; 2000 Apr; 105(7):1013-21. PubMed ID: 10749580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoting effects of serotonin on hematopoiesis: ex vivo expansion of cord blood CD34+ stem/progenitor cells, proliferation of bone marrow stromal cells, and antiapoptosis.
    Yang M; Li K; Ng PC; Chuen CK; Lau TK; Cheng YS; Liu YS; Li CK; Yuen PM; James AE; Lee SM; Fok TF
    Stem Cells; 2007 Jul; 25(7):1800-6. PubMed ID: 17446559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small peptide analogue of SDF-1alpha supports survival of cord blood CD34+ cells in synergy with other cytokines and enhances their ex vivo expansion and engraftment into nonobese diabetic/severe combined immunodeficient mice.
    Li K; Chuen CK; Lee SM; Law P; Fok TF; Ng PC; Li CK; Wong D; Merzouk A; Salari H; Gu GJ; Yuen PM
    Stem Cells; 2006 Jan; 24(1):55-64. PubMed ID: 16123381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo expansion of stem cells: defining optimum conditions using various cytokines.
    Mohamed AA; Ibrahim AM; El-Masry MW; Mansour IM; Khroshied MA; Gouda HM; Riad RM
    Lab Hematol; 2006; 12(2):86-93. PubMed ID: 16751136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of different medium and growth factors on placental blood stem cell expansion: an in vitro and in vivo study.
    Berger M; Fagioli F; Piacibello W; Sanavio F; Mareschi K; Biasin E; Bruno S; Gammaitoni L; Gunetti M; Nesi F; Madon E; Aglietta M
    Bone Marrow Transplant; 2002 Mar; 29(5):443-8. PubMed ID: 11919735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of IL-6/sIL-6R on ex vivo expansion of human cord blood derived CD34+ cells].
    Feng JF; Zhuang M; Zhu LJ; Sheng ZL; Zhu YQ; Li CP
    Ai Zheng; 2004 Jun; 23(6):715-8. PubMed ID: 15191679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells.
    Lazzari L; Henschler R; Lecchi L; Rebulla P; Mertelsmann R; Sirchia G
    Haematologica; 2000 Jan; 85(1):25-30. PubMed ID: 10629587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical ex vivo expansion of G-CSF-mobilized peripheral blood stem cells: effects of serum-free media, cytokine combinations and chemotherapy.
    Li K; Li CK; Chuen CK; Tsang KS; Fok TF; James AE; Lee SM; Shing MM; Chik KW; Yuen PM
    Eur J Haematol; 2005 Feb; 74(2):128-35. PubMed ID: 15654904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of different thawing methods, growth factor combinations and media on the ex vivo expansion of umbilical cord blood primitive and committed progenitors.
    Kögler G; Callejas J; Sorg RV; Fischer J; Migliaccio AR; Wernet P
    Bone Marrow Transplant; 1998 Feb; 21(3):233-41. PubMed ID: 9489645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo culture of human CD34+ cord blood cells with thrombopoietin (TPO) accelerates platelet engraftment in a NOD/SCID mouse model.
    van Hensbergen Y; Schipper LF; Brand A; Slot MC; Welling M; Nauta AJ; Fibbe WE
    Exp Hematol; 2006 Jul; 34(7):943-50. PubMed ID: 16797422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-derived growth factor enhances ex vivo expansion of megakaryocytic progenitors from human cord blood.
    Su RJ; Li K; Yang M; Zhang XB; Tsang KS; Fok TF; Li CK; Yuen PM
    Bone Marrow Transplant; 2001 May; 27(10):1075-80. PubMed ID: 11438824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effects of hepatocyte growth factor on human cord blood CD34+ progenitor cells are the result of c-met receptor expression.
    Goff JP; Shields DS; Petersen BE; Zajac VF; Michalopoulos GK; Greenberger JS
    Stem Cells; 1996 Sep; 14(5):592-602. PubMed ID: 8888500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.